JP2013509360A5 - - Google Patents

Download PDF

Info

Publication number
JP2013509360A5
JP2013509360A5 JP2012535616A JP2012535616A JP2013509360A5 JP 2013509360 A5 JP2013509360 A5 JP 2013509360A5 JP 2012535616 A JP2012535616 A JP 2012535616A JP 2012535616 A JP2012535616 A JP 2012535616A JP 2013509360 A5 JP2013509360 A5 JP 2013509360A5
Authority
JP
Japan
Prior art keywords
taxol
steroid
complex according
organic solvent
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012535616A
Other languages
English (en)
Japanese (ja)
Other versions
JP6158513B2 (ja
JP2013509360A (ja
Filing date
Publication date
Priority claimed from CN200910236960.7A external-priority patent/CN102048725B/zh
Application filed filed Critical
Publication of JP2013509360A publication Critical patent/JP2013509360A/ja
Publication of JP2013509360A5 publication Critical patent/JP2013509360A5/ja
Application granted granted Critical
Publication of JP6158513B2 publication Critical patent/JP6158513B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012535616A 2009-10-29 2010-10-28 タクソール/ステロイド化合物 Active JP6158513B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200910236960.7A CN102048725B (zh) 2009-10-29 2009-10-29 紫杉醇胆固醇复合物
CN200910236960.7 2009-10-29
PCT/CN2010/078202 WO2011050735A1 (zh) 2009-10-29 2010-10-28 紫杉醇/类固醇复合物

Publications (3)

Publication Number Publication Date
JP2013509360A JP2013509360A (ja) 2013-03-14
JP2013509360A5 true JP2013509360A5 (enExample) 2017-01-12
JP6158513B2 JP6158513B2 (ja) 2017-07-12

Family

ID=43921347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012535616A Active JP6158513B2 (ja) 2009-10-29 2010-10-28 タクソール/ステロイド化合物

Country Status (9)

Country Link
US (1) US20130150335A1 (enExample)
EP (1) EP2494956A4 (enExample)
JP (1) JP6158513B2 (enExample)
KR (1) KR20120091258A (enExample)
CN (2) CN102048725B (enExample)
AU (1) AU2010312017B2 (enExample)
BR (1) BR112012010149A2 (enExample)
CA (1) CA2779316C (enExample)
WO (1) WO2011050735A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102048688B (zh) * 2009-10-29 2014-03-05 中国医学科学院药物研究所 以胆固醇复合物为中间载体的紫杉醇亚微乳
EP2679225A1 (de) * 2012-06-26 2014-01-01 Universitätsklinikum Freiburg Pharmazeutische Zusammensetzung mit synergistischer Wirkung von direkten Katalaseinhibitoren und zur Katalasezerstörung führenden Modulatoren des NO-Stoffwechsels oder der extrazellulären Superoxidanionenproduktion
AU2018283411B2 (en) 2017-06-16 2021-04-29 Sorse Technology Corporation Preparing stable liquid emulsion forms of plant extract
CN108272747B (zh) * 2018-03-16 2020-02-18 武汉百纳礼康生物制药有限公司 一种非那雄胺溶致液晶凝胶制剂前体及其制备方法
BR112021005104A2 (pt) 2018-10-16 2021-06-08 US Nano Food & Drug INC formulação de injeção intratumoral
JP2023520975A (ja) 2020-04-13 2023-05-23 ユーエス・ナノ・フード・アンド・ドラッグ・インコーポレーテッド 塩基性化学療法腫瘍内注射製剤
KR102789632B1 (ko) * 2021-04-01 2025-04-01 에스엔제이 파마 인크 생활성물질의 경구용 나노입자 및 이의 제조방법
CN115177589B (zh) * 2021-04-07 2024-02-06 中国医学科学院药物研究所 一种紫杉醇脑靶向脂质体和其制备方法及应用
CN115463110B (zh) * 2021-06-10 2023-12-15 中国医学科学院药物研究所 一种胆酸修饰的口服紫杉醇纳米粒、其制备方法及应用
CN115737654B (zh) * 2021-09-03 2025-11-21 成都瑞沐生物医药科技有限公司 一种滴眼给药预防和/或治疗白内障的眼用制剂
CN116196283A (zh) * 2021-11-30 2023-06-02 深圳玖星制药有限公司 一种注射用紫杉烷类药物脂质体冻干粉剂的制备方法及原料组方
CN117482052A (zh) * 2023-11-29 2024-02-02 中国药科大学 一种口服紫杉醇三元递药系统及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
CN1116875C (zh) * 2000-10-19 2003-08-06 南京振中生物工程有限公司 紫杉醇脂质组合物及其制备方法
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
CN101396343B (zh) * 2007-09-26 2011-12-07 中国医学科学院药物研究所 以脂质复合物为中间载体的紫杉醇亚微乳
CN102048688B (zh) * 2009-10-29 2014-03-05 中国医学科学院药物研究所 以胆固醇复合物为中间载体的紫杉醇亚微乳

Similar Documents

Publication Publication Date Title
Hanson Steroids: partial synthesis in medicinal chemistry
JP5657052B2 (ja) Cns疾患治療用医薬組成物の製造のためのプレグナンおよびアンドロスタンステロイドの使用
JP2011157386A5 (enExample)
JP2010500285A (ja) Fxr媒介疾患または状態の予防または治療のためのfxrリガンドとしての胆汁酸誘導体
CN110028547B (zh) 一种薯蓣皂苷元3-oh衍生物及其制备方法和医药用途
CN105143241A (zh) 用于制备固体形式的乙酸阿比特龙的方法
CN105348351B (zh) 制备甲基四烯物的方法
JP2008534533A5 (enExample)
DE2529521C2 (de) Verfahren zur Gewinnung von 3-Hydroxysteroiden und 3-Oxosteroiden
CH630334A5 (de) Verfahren zur herstellung von carbonsaeureestern.
JP2011511823A5 (enExample)
CN102451176B (zh) 多西紫杉烷/类固醇复合物
CN107108761B (zh) 硫酸软骨素衍生物和膀胱疾病处置剂
Wang et al. First synthesis of 22-oxa-chenodeoxycholic acid analogue
Özdemir et al. Amphiphilic derivatives of (3β, 17β)-3-hydroxyandrost-5-ene-17-carboxylic acid
CN104119414A (zh) 高质量黄体酮的制备方法
JP2007326855A (ja) 新規配糖体
CN108147963A (zh) 一种天然产物凝胶质的制备方法
EP2506855A1 (en) Anticancer compounds and screening method
JP2019504866A5 (enExample)
CN104059118A (zh) 高效立体选择性一步还原甾体骨架中的4-烯-3-酮为3a-羟基-5b-氢A/B顺式结构的方法
EP0875515B1 (en) Sulfatation of estrogen mixtures
Rijk et al. Bioassay based screening of steroid derivatives in animal feed and supplements
YE Chemical constituents from Isodon coetsa distributed in Guizhou
CN103265600B (zh) 一种合成醋酸孕烯酮醇的方法